CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on personalized cancer treatment by identifying specific biomarkers that predict drug response. It utilizes advanced genomic technologies to analyze pancreatic cancer and aims to match therapies to individual tumor characteristics, enhancing treatment efficacy.
The dawn of the age of personalized cancer treatment provides the promise to identify the right drug for the individual that will greatly improve the patient’s outcome.
It is well known that cancer drugs work only in small subset of patients.
For many of these agents, there are putative markers of response in the literature but very few are been used in clinical practice.
More importantly, new anticancer agents are targeted to specific cancer genes and are expected to be effective only in tumo…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
